West Pharmaceutical Services (BSP:W2ST34) YoY EBITDA Growth : -16.45% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is West Pharmaceutical Services YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. West Pharmaceutical Services's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -16.45%.

West Pharmaceutical Services's EBITDA per Share for the three months ended in Mar. 2024 was R$0.32.

West Pharmaceutical Services YoY EBITDA Growth Historical Data

The historical data trend for West Pharmaceutical Services's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services YoY EBITDA Growth Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

20.77

60.19

85.09

-14.18

-1.75

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-8.27	-17.24	27.03	19.94	-16.45

West Pharmaceutical Services YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

West Pharmaceutical Services's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(1.57	-	1.598)	/	\| 1.598 \|
=	-1.75 %

West Pharmaceutical Services's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.315	-	0.377)	/	\| 0.377 \|
=	-16.45 %

West Pharmaceutical Services YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (BSP:W2ST34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (BSP:W2ST34) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.

West Pharmaceutical Services (BSP:W2ST34) Headlines

No Headlines